Loading insider details...
Beta
Latest Form 4 (Jun 12, 2026): Exercise/Conversion of 43,973 CTKB shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 12, 2026 | Cytek Biosciences, Inc. (CTKB) | Exercise/Conversion | 43,973 | n/a |
| Jun 20, 2025 | Cytek Biosciences, Inc. (CTKB) | Grant/Award | 43,973 | n/a |
| Jun 9, 2025 | Cytek Biosciences, Inc. (CTKB) | Exercise/Conversion | 15,706 | n/a |
| Jun 7, 2024 | Cytek Biosciences, Inc. (CTKB) | Grant/Award | 15,706 | n/a |
| Jun 16, 2023 | Cytek Biosciences, Inc. (CTKB) | Grant/Award | 30,242 | n/a |
| Nov 30, 2022 | Cytek Biosciences, Inc. (CTKB) | Exercise/Conversion | 10,666 | $4.3K |
| Nov 16, 2022 | Cytek Biosciences, Inc. (CTKB) | Exercise/Conversion | 16,000 | $6.4K |
| Jun 3, 2022 | Cytek Biosciences, Inc. (CTKB) | Grant/Award | 25,789 | n/a |
| Jul 27, 2021 | Cytek Biosciences, Inc. (CTKB) | Purchase | 3,000 | $51.0K |